80 related articles for article (PubMed ID: 19883274)
21. Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells.
Yang J; Sun M; Zhang A; Lv C; De W; Wang Z
World J Surg Oncol; 2011 Oct; 9():117. PubMed ID: 21970601
[TBL] [Abstract][Full Text] [Related]
22. Significance of Bcl-xL in human colon carcinoma.
Zhang YL; Pang LQ; Wu Y; Wang XY; Wang CQ; Fan Y
World J Gastroenterol; 2008 May; 14(19):3069-73. PubMed ID: 18494061
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
24. GLUT1 and Bcl-xL in relation to erythropoietin in human colorectal adenocarcinomas.
Wincewicz A; Baltaziak M; Kanczuga-Koda L; Koda M; Sulkowska U; Sulkowski S
Hepatogastroenterology; 2010; 57(101):741-5. PubMed ID: 21033220
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
[TBL] [Abstract][Full Text] [Related]
26. Bcl-xL overexpression in human hepatocellular carcinoma.
Watanabe J; Kushihata F; Honda K; Mominoki K; Matsuda S; Kobayashi N
Int J Oncol; 2002 Sep; 21(3):515-9. PubMed ID: 12168094
[TBL] [Abstract][Full Text] [Related]
27. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma.
Shimizu S; Takehara T; Hikita H; Kodama T; Miyagi T; Hosui A; Tatsumi T; Ishida H; Noda T; Nagano H; Doki Y; Mori M; Hayashi N
J Hepatol; 2010 May; 52(5):698-704. PubMed ID: 20347499
[TBL] [Abstract][Full Text] [Related]
28. Significance of decreased apoptosis, role of Bid expression and Bcl-Xl/Bid ratio in human jejunal stromal tumors.
Gao C; Guo WJ; Wang AY
APMIS; 2012 Mar; 120(3):171-81. PubMed ID: 22339673
[TBL] [Abstract][Full Text] [Related]
29. Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder: which protein is prognostic?
Hameed DA; Abdel Raheem AM; Mosad E; Hammouda HM; Kamel NA; Abdel Aziz MA
Urology; 2008 Aug; 72(2):374-8. PubMed ID: 18342927
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
31. Lack of expression of surface immunoglobulin light chains in B-cell non-Hodgkin lymphomas.
Kaleem Z; Zehnbauer BA; White G; Zutter MM
Am J Clin Pathol; 2000 Mar; 113(3):399-405. PubMed ID: 10705821
[TBL] [Abstract][Full Text] [Related]
32. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological correlations of Bcl-xL and Bax expression in differentiated thyroid carcinoma.
Martínez-Brocca MA; Castilla C; Navarro E; Amaya MJ; Travado P; Japón MA; Sáez C
Clin Endocrinol (Oxf); 2008 Feb; 68(2):190-7. PubMed ID: 17803695
[TBL] [Abstract][Full Text] [Related]
34. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
[TBL] [Abstract][Full Text] [Related]
35. Over-expression of Bcl-2 against Pteris semipinnata L-induced apoptosis of human colon cancer cells via a NF-kappa B-related pathway.
Chen GG; Liang NC; Lee JF; Chan UP; Wang SH; Leung BC; Leung KL
Apoptosis; 2004 Sep; 9(5):619-27. PubMed ID: 15314290
[TBL] [Abstract][Full Text] [Related]
36. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
[TBL] [Abstract][Full Text] [Related]
37. [Expression and recombination mechanism of SNC73 (IgHalpha1) in human epithelial cancer cell line].
Geng LY; Zheng S; Peng JP
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1493-6. PubMed ID: 14521728
[TBL] [Abstract][Full Text] [Related]
38. Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer.
Magnusson C; Mezhybovska M; Lörinc E; Fernebro E; Nilbert M; Sjölander A
Eur J Cancer; 2010 Mar; 46(4):826-35. PubMed ID: 20064706
[TBL] [Abstract][Full Text] [Related]
39. RNA interference by expression of short hairpin RNAs suppresses bcl-xL gene expression in nasopharyngeal carcinoma cells.
Liu F; He CW; Zhang YF; Zhou KY
Acta Pharmacol Sin; 2005 Feb; 26(2):228-34. PubMed ID: 15663904
[TBL] [Abstract][Full Text] [Related]
40. Significant coexpression of GLUT-1, Bcl-xL, and Bax in colorectal cancer.
Wincewicz A; Sulkowska M; Koda M; Kanczuga-Koda L; Witkowska E; Sulkowski S
Ann N Y Acad Sci; 2007 Jan; 1095():53-61. PubMed ID: 17404017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
